Physician profile
Matthew L Esson
NPI 1760473250
$626.74
in general payments reported to CMS, 2019-2025
10 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.20 · 2020: $141 · 2021: $12.86 · 2022: $200 · 2024: $26.43 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $211.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $117.60 | 2022 | |
| Boston Scientific Corporation | $114.99 | 2025 | Watchman Access System |
| Otsuka America Pharmaceutical, INC. | $87.63 | 2019-2024 | Jynarque |
| Nxstage Medical, INC. | $83.66 | 2020 | |
| W. L. Gore & Associates, INC. | $82.43 | 2022 | |
| Amgen INC. | $44.79 | 2025 | Krystexxa, Tavneos |
| Janssen Pharmaceuticals, INC | $43.96 | 2020 | |
| Akebia Therapeutics INC | $25.62 | 2025 | Vafseo |
| Rockwell Medical, INC. | $13.20 | 2020 | |
| Bard Peripheral Vascular, INC. | $12.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Esson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.